Cooley M&A

OCTOBER 19, 2022

Some of the tax provisions contained in the legislation, including the 1% excise tax on certain stock buybacks, may impact special purpose acquisition companies (SPACs) at key points in their life cycle. Biotech Company ViaCyte to Be Acquired by Vertex Pharmaceuticals. Notable public deals. DigitalOcean Agrees to Buy Cloudways.

M&A 69

M&A Initial Public Offering Pharmaceutical Medical 69

Cooley M&A

JANUARY 22, 2020

A wave of big-ticket transactions by global pharmaceutical companies drove life sciences M&A activity to its fourth-largest year on record in 2019, with aggregate deal value in the pharmaceutical, medical and biotech industry reaching $234.2 billion acquisition of The Medicines Company. The Art of the Life Sciences Deal.

M&A 40

M&A Pharmaceutical Acquisitions Capital 40

Cooley M&A

JANUARY 25, 2023

But it wasn’t all carve outs and concerned investors – even with the headwinds in the industry and beyond, there were still several traditional public M&A deals involving biotechnology or medical device companies, as large pharmaceutical companies continued to have cash to deploy for acquisitions.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Collaboration 40

Cooley M&A

JANUARY 20, 2022

1] Major all-cash acquisitions have followed, such as Arena Pharmaceutical’s agreement to sell to Pfizer for $6.7 1] Major all-cash acquisitions have followed, such as Arena Pharmaceutical’s agreement to sell to Pfizer for $6.7 billion , Acceleron Pharma’s agreement to sell to Merck for $11.5 With COVID?19

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Mergers 40